These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
662 related articles for article (PubMed ID: 9774669)
41. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer. Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931 [TBL] [Abstract][Full Text] [Related]
42. Tagging methyl-CpG-binding domain proteins reveals different spatiotemporal expression and supports distinct functions. Wood KH; Johnson BS; Welsh SA; Lee JY; Cui Y; Krizman E; Brodkin ES; Blendy JA; Robinson MB; Bartolomei MS; Zhou Z Epigenomics; 2016 Apr; 8(4):455-73. PubMed ID: 27066839 [TBL] [Abstract][Full Text] [Related]
43. Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. Magdinier F; Wolffe AP Proc Natl Acad Sci U S A; 2001 Apr; 98(9):4990-5. PubMed ID: 11309512 [TBL] [Abstract][Full Text] [Related]
44. Arabidopsis MBD proteins show different binding specificities and nuclear localization. Scebba F; Bernacchia G; De Bastiani M; Evangelista M; Cantoni RM; Cella R; Locci MT; Pitto L Plant Mol Biol; 2003 Nov; 53(5):715-31. PubMed ID: 15010609 [TBL] [Abstract][Full Text] [Related]
45. MBD2-MBD3 complex binds to hemi-methylated DNA and forms a complex containing DNMT1 at the replication foci in late S phase. Tatematsu KI; Yamazaki T; Ishikawa F Genes Cells; 2000 Aug; 5(8):677-88. PubMed ID: 10947852 [TBL] [Abstract][Full Text] [Related]
46. Specific binding of the methyl binding domain protein 2 at the BRCA1-NBR2 locus. Auriol E; Billard LM; Magdinier F; Dante R Nucleic Acids Res; 2005; 33(13):4243-54. PubMed ID: 16052033 [TBL] [Abstract][Full Text] [Related]
47. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Le Guezennec X; Vermeulen M; Brinkman AB; Hoeijmakers WA; Cohen A; Lasonder E; Stunnenberg HG Mol Cell Biol; 2006 Feb; 26(3):843-51. PubMed ID: 16428440 [TBL] [Abstract][Full Text] [Related]
48. Preferential binding of the methyl-CpG binding domain protein 2 at methylated transcriptional start site regions. Chatagnon A; Perriaud L; Nazaret N; Croze S; Benhattar J; Lachuer J; Dante R Epigenetics; 2011 Nov; 6(11):1295-307. PubMed ID: 22048253 [TBL] [Abstract][Full Text] [Related]
49. Methyl CpG-binding proteins and transcriptional repression. Wade PA Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232 [TBL] [Abstract][Full Text] [Related]
50. The mCpG-binding domain of human MBD3 does not bind to mCpG but interacts with NuRD/Mi2 components HDAC1 and MTA2. Saito M; Ishikawa F J Biol Chem; 2002 Sep; 277(38):35434-9. PubMed ID: 12124384 [TBL] [Abstract][Full Text] [Related]
51. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Zhang Y; Ng HH; Erdjument-Bromage H; Tempst P; Bird A; Reinberg D Genes Dev; 1999 Aug; 13(15):1924-35. PubMed ID: 10444591 [TBL] [Abstract][Full Text] [Related]
52. CpG island promoter methylation and silencing of 14-3-3sigma gene expression in LNCaP and Tramp-C1 prostate cancer cell lines is associated with methyl-CpG-binding protein MBD2. Pulukuri SM; Rao JS Oncogene; 2006 Aug; 25(33):4559-72. PubMed ID: 16786000 [TBL] [Abstract][Full Text] [Related]
53. CpG-methylation regulates a class of Epstein-Barr virus promoters. Bergbauer M; Kalla M; Schmeinck A; Göbel C; Rothbauer U; Eck S; Benet-Pagès A; Strom TM; Hammerschmidt W PLoS Pathog; 2010 Sep; 6(9):e1001114. PubMed ID: 20886097 [TBL] [Abstract][Full Text] [Related]
54. Identification and functional characterization of the p66/p68 components of the MeCP1 complex. Feng Q; Cao R; Xia L; Erdjument-Bromage H; Tempst P; Zhang Y Mol Cell Biol; 2002 Jan; 22(2):536-46. PubMed ID: 11756549 [TBL] [Abstract][Full Text] [Related]
55. RET finger protein enhances MBD2- and MBD4-dependent transcriptional repression. Fukushige S; Kondo E; Gu Z; Suzuki H; Horii A Biochem Biophys Res Commun; 2006 Dec; 351(1):85-92. PubMed ID: 17049487 [TBL] [Abstract][Full Text] [Related]
56. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines. Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420 [TBL] [Abstract][Full Text] [Related]
58. The human proteins MBD5 and MBD6 associate with heterochromatin but they do not bind methylated DNA. Laget S; Joulie M; Le Masson F; Sasai N; Christians E; Pradhan S; Roberts RJ; Defossez PA PLoS One; 2010 Aug; 5(8):e11982. PubMed ID: 20700456 [TBL] [Abstract][Full Text] [Related]
59. Dynamics of MBD2 deposition across methylated DNA regions during malignant transformation of human mammary epithelial cells. Devailly G; Grandin M; Perriaud L; Mathot P; Delcros JG; Bidet Y; Morel AP; Bignon JY; Puisieux A; Mehlen P; Dante R Nucleic Acids Res; 2015 Jul; 43(12):5838-54. PubMed ID: 26007656 [TBL] [Abstract][Full Text] [Related]
60. DNA binding selectivity of MeCP2 due to a requirement for A/T sequences adjacent to methyl-CpG. Klose RJ; Sarraf SA; Schmiedeberg L; McDermott SM; Stancheva I; Bird AP Mol Cell; 2005 Sep; 19(5):667-78. PubMed ID: 16137622 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]